nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—Sulfaphenazole—Sulfasalazine—ulcerative colitis	0.17	1	CrCrCtD
Celecoxib—hematologic cancer—Methylprednisolone—ulcerative colitis	0.0885	0.238	CpDpCtD
Celecoxib—PTGS2—ulcerative colitis	0.07	0.529	CbGaD
Celecoxib—ALB—ulcerative colitis	0.0624	0.471	CbGaD
Celecoxib—kidney cancer—Hydrocortisone—ulcerative colitis	0.0472	0.127	CpDpCtD
Celecoxib—colon cancer—Dexamethasone—ulcerative colitis	0.0399	0.107	CpDpCtD
Celecoxib—colon cancer—Betamethasone—ulcerative colitis	0.0399	0.107	CpDpCtD
Celecoxib—prostate cancer—Hydrocortisone—ulcerative colitis	0.0342	0.0917	CpDpCtD
Celecoxib—PTGS2—Olsalazine—ulcerative colitis	0.0299	0.151	CbGbCtD
Celecoxib—kidney cancer—Dexamethasone—ulcerative colitis	0.0288	0.0774	CpDpCtD
Celecoxib—kidney cancer—Betamethasone—ulcerative colitis	0.0288	0.0774	CpDpCtD
Celecoxib—PTGS2—Balsalazide—ulcerative colitis	0.0267	0.134	CbGbCtD
Celecoxib—ABCC4—Mercaptopurine—ulcerative colitis	0.0248	0.125	CbGbCtD
Celecoxib—PTGS2—Mesalazine—ulcerative colitis	0.0213	0.107	CbGbCtD
Celecoxib—prostate cancer—Dexamethasone—ulcerative colitis	0.0208	0.056	CpDpCtD
Celecoxib—prostate cancer—Betamethasone—ulcerative colitis	0.0208	0.056	CpDpCtD
Celecoxib—PTGS2—Sulfasalazine—ulcerative colitis	0.0119	0.0599	CbGbCtD
Celecoxib—PTGS2—Triamcinolone—ulcerative colitis	0.0119	0.0599	CbGbCtD
Celecoxib—osteoarthritis—Methylprednisolone—ulcerative colitis	0.0117	0.0315	CpDpCtD
Celecoxib—osteoarthritis—Prednisone—ulcerative colitis	0.0117	0.0315	CpDpCtD
Celecoxib—PTGS2—Betamethasone—ulcerative colitis	0.0102	0.0514	CbGbCtD
Celecoxib—CYP3A4—Budesonide—ulcerative colitis	0.00695	0.035	CbGbCtD
Celecoxib—ALB—Prednisone—ulcerative colitis	0.006	0.0302	CbGbCtD
Celecoxib—PTGS2—Dexamethasone—ulcerative colitis	0.00594	0.0299	CbGbCtD
Celecoxib—CYP2C9—Nicotine—ulcerative colitis	0.0052	0.0262	CbGbCtD
Celecoxib—CYP2D6—Nicotine—ulcerative colitis	0.00476	0.024	CbGbCtD
Celecoxib—CYP2C9—Cholecalciferol—ulcerative colitis	0.00467	0.0235	CbGbCtD
Celecoxib—CYP2D6—Cholecalciferol—ulcerative colitis	0.00427	0.0215	CbGbCtD
Celecoxib—CYP3A4—Methylprednisolone—ulcerative colitis	0.0031	0.0156	CbGbCtD
Celecoxib—CYP3A4—Nicotine—ulcerative colitis	0.00303	0.0152	CbGbCtD
Celecoxib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00271	0.0137	CbGbCtD
Celecoxib—ORM1—bile—ulcerative colitis	0.00236	0.203	CbGeAlD
Celecoxib—CYP3A4—Triamcinolone—ulcerative colitis	0.00235	0.0118	CbGbCtD
Celecoxib—CYP2C9—Dexamethasone—ulcerative colitis	0.00202	0.0102	CbGbCtD
Celecoxib—CYP3A4—Betamethasone—ulcerative colitis	0.00202	0.0102	CbGbCtD
Celecoxib—CYP3A4—Prednisolone—ulcerative colitis	0.00199	0.01	CbGbCtD
Celecoxib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00189	0.00951	CbGbCtD
Celecoxib—CYP3A4—Prednisone—ulcerative colitis	0.00188	0.00947	CbGbCtD
Celecoxib—CYP2D6—Dexamethasone—ulcerative colitis	0.00185	0.0093	CbGbCtD
Celecoxib—CYP3A4—Dexamethasone—ulcerative colitis	0.00117	0.00591	CbGbCtD
Celecoxib—PDPK1—lymphoid tissue—ulcerative colitis	0.000811	0.0699	CbGeAlD
Celecoxib—PDPK1—digestive system—ulcerative colitis	0.000801	0.069	CbGeAlD
Celecoxib—PDPK1—liver—ulcerative colitis	0.000597	0.0514	CbGeAlD
Celecoxib—MAPK14—epithelium—ulcerative colitis	0.000563	0.0485	CbGeAlD
Celecoxib—CA5A—liver—ulcerative colitis	0.00056	0.0483	CbGeAlD
Celecoxib—MAPK14—smooth muscle tissue—ulcerative colitis	0.000543	0.0468	CbGeAlD
Celecoxib—CA9—digestive system—ulcerative colitis	0.00044	0.0379	CbGeAlD
Celecoxib—MAPK14—lymphoid tissue—ulcerative colitis	0.000434	0.0374	CbGeAlD
Celecoxib—MAPK14—digestive system—ulcerative colitis	0.000429	0.0369	CbGeAlD
Celecoxib—CA12—digestive system—ulcerative colitis	0.000325	0.028	CbGeAlD
Celecoxib—MAPK14—liver—ulcerative colitis	0.000319	0.0275	CbGeAlD
Celecoxib—CA14—liver—ulcerative colitis	0.000311	0.0268	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000288	0.247	CbGdCrCtD
Celecoxib—Etoricoxib—PTGS2—ulcerative colitis	0.000261	1	CrCbGaD
Celecoxib—CA2—epithelium—ulcerative colitis	0.000219	0.0189	CbGeAlD
Celecoxib—ABCC4—digestive system—ulcerative colitis	0.000219	0.0189	CbGeAlD
Celecoxib—CA2—smooth muscle tissue—ulcerative colitis	0.000211	0.0182	CbGeAlD
Celecoxib—CA4—digestive system—ulcerative colitis	0.000201	0.0173	CbGeAlD
Celecoxib—ORM1—liver—ulcerative colitis	0.000192	0.0166	CbGeAlD
Celecoxib—CA2—lymphoid tissue—ulcerative colitis	0.000169	0.0146	CbGeAlD
Celecoxib—ALB—liver—ulcerative colitis	0.000169	0.0145	CbGeAlD
Celecoxib—CA2—digestive system—ulcerative colitis	0.000167	0.0144	CbGeAlD
Celecoxib—ABCC4—liver—ulcerative colitis	0.000163	0.0141	CbGeAlD
Celecoxib—PTGS2—epithelium—ulcerative colitis	0.000162	0.014	CbGeAlD
Celecoxib—PTGS2—smooth muscle tissue—ulcerative colitis	0.000156	0.0134	CbGeAlD
Celecoxib—CYP2C9—digestive system—ulcerative colitis	0.000141	0.0122	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000139	0.119	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000137	0.118	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000137	0.118	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000134	0.115	CbGdCrCtD
Celecoxib—PTGS2—lymphoid tissue—ulcerative colitis	0.000125	0.0107	CbGeAlD
Celecoxib—CA2—liver—ulcerative colitis	0.000124	0.0107	CbGeAlD
Celecoxib—PTGS2—digestive system—ulcerative colitis	0.000123	0.0106	CbGeAlD
Celecoxib—CYP3A4—digestive system—ulcerative colitis	0.000108	0.00928	CbGeAlD
Celecoxib—CYP2D6—digestive system—ulcerative colitis	0.000106	0.00913	CbGeAlD
Celecoxib—CYP2C9—liver—ulcerative colitis	0.000105	0.00906	CbGeAlD
Celecoxib—PTGS2—liver—ulcerative colitis	9.18e-05	0.00791	CbGeAlD
Celecoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	8.39e-05	0.0721	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	8.26e-05	0.0709	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	8.26e-05	0.0709	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	8.07e-05	0.0693	CbGdCrCtD
Celecoxib—CYP3A4—liver—ulcerative colitis	8.02e-05	0.00691	CbGeAlD
Celecoxib—CYP2D6—liver—ulcerative colitis	7.89e-05	0.0068	CbGeAlD
Celecoxib—Vertigo—Methylprednisolone—ulcerative colitis	2.75e-05	0.000386	CcSEcCtD
Celecoxib—Syncope—Methylprednisolone—ulcerative colitis	2.74e-05	0.000385	CcSEcCtD
Celecoxib—Connective tissue disorder—Prednisone—ulcerative colitis	2.73e-05	0.000384	CcSEcCtD
Celecoxib—Nausea—Budesonide—ulcerative colitis	2.73e-05	0.000383	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisolone—ulcerative colitis	2.72e-05	0.000382	CcSEcCtD
Celecoxib—Oedema—Prednisolone—ulcerative colitis	2.72e-05	0.000382	CcSEcCtD
Celecoxib—Dizziness—Azathioprine—ulcerative colitis	2.71e-05	0.000381	CcSEcCtD
Celecoxib—Loss of consciousness—Triamcinolone—ulcerative colitis	2.69e-05	0.000379	CcSEcCtD
Celecoxib—Loss of consciousness—Methylprednisolone—ulcerative colitis	2.69e-05	0.000378	CcSEcCtD
Celecoxib—Asthenia—Mesalazine—ulcerative colitis	2.68e-05	0.000377	CcSEcCtD
Celecoxib—Shock—Prednisolone—ulcerative colitis	2.68e-05	0.000376	CcSEcCtD
Celecoxib—Cough—Triamcinolone—ulcerative colitis	2.67e-05	0.000376	CcSEcCtD
Celecoxib—Anaphylactic shock—Hydrocortisone—ulcerative colitis	2.66e-05	0.000373	CcSEcCtD
Celecoxib—Oedema—Hydrocortisone—ulcerative colitis	2.66e-05	0.000373	CcSEcCtD
Celecoxib—Tachycardia—Prednisolone—ulcerative colitis	2.65e-05	0.000373	CcSEcCtD
Celecoxib—Hypertension—Triamcinolone—ulcerative colitis	2.65e-05	0.000372	CcSEcCtD
Celecoxib—Pruritus—Mesalazine—ulcerative colitis	2.64e-05	0.000371	CcSEcCtD
Celecoxib—Hypertension—Methylprednisolone—ulcerative colitis	2.64e-05	0.000371	CcSEcCtD
Celecoxib—Infection—Hydrocortisone—ulcerative colitis	2.64e-05	0.000371	CcSEcCtD
Celecoxib—Hyperhidrosis—Prednisolone—ulcerative colitis	2.63e-05	0.00037	CcSEcCtD
Celecoxib—Shock—Hydrocortisone—ulcerative colitis	2.61e-05	0.000367	CcSEcCtD
Celecoxib—Myalgia—Triamcinolone—ulcerative colitis	2.61e-05	0.000367	CcSEcCtD
Celecoxib—Vomiting—Azathioprine—ulcerative colitis	2.61e-05	0.000366	CcSEcCtD
Celecoxib—Nervous system disorder—Hydrocortisone—ulcerative colitis	2.6e-05	0.000366	CcSEcCtD
Celecoxib—Arthralgia—Methylprednisolone—ulcerative colitis	2.6e-05	0.000366	CcSEcCtD
Celecoxib—Myalgia—Methylprednisolone—ulcerative colitis	2.6e-05	0.000366	CcSEcCtD
Celecoxib—Eye disorder—Prednisone—ulcerative colitis	2.6e-05	0.000365	CcSEcCtD
Celecoxib—Anxiety—Methylprednisolone—ulcerative colitis	2.59e-05	0.000365	CcSEcCtD
Celecoxib—Tachycardia—Hydrocortisone—ulcerative colitis	2.59e-05	0.000364	CcSEcCtD
Celecoxib—Rash—Azathioprine—ulcerative colitis	2.59e-05	0.000363	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	2.58e-05	0.000363	CcSEcCtD
Celecoxib—Dermatitis—Azathioprine—ulcerative colitis	2.58e-05	0.000363	CcSEcCtD
Celecoxib—Flushing—Prednisone—ulcerative colitis	2.58e-05	0.000363	CcSEcCtD
Celecoxib—Skin disorder—Hydrocortisone—ulcerative colitis	2.58e-05	0.000363	CcSEcCtD
Celecoxib—Headache—Azathioprine—ulcerative colitis	2.57e-05	0.000361	CcSEcCtD
Celecoxib—Hyperhidrosis—Hydrocortisone—ulcerative colitis	2.57e-05	0.000361	CcSEcCtD
Celecoxib—Diarrhoea—Mesalazine—ulcerative colitis	2.56e-05	0.000359	CcSEcCtD
Celecoxib—Dry mouth—Triamcinolone—ulcerative colitis	2.55e-05	0.000359	CcSEcCtD
Celecoxib—Angioedema—Betamethasone—ulcerative colitis	2.54e-05	0.000357	CcSEcCtD
Celecoxib—Angioedema—Dexamethasone—ulcerative colitis	2.54e-05	0.000357	CcSEcCtD
Celecoxib—Anorexia—Hydrocortisone—ulcerative colitis	2.53e-05	0.000356	CcSEcCtD
Celecoxib—Angiopathy—Prednisone—ulcerative colitis	2.52e-05	0.000355	CcSEcCtD
Celecoxib—Confusional state—Methylprednisolone—ulcerative colitis	2.52e-05	0.000354	CcSEcCtD
Celecoxib—Immune system disorder—Prednisone—ulcerative colitis	2.51e-05	0.000353	CcSEcCtD
Celecoxib—Oedema—Triamcinolone—ulcerative colitis	2.5e-05	0.000352	CcSEcCtD
Celecoxib—Anaphylactic shock—Triamcinolone—ulcerative colitis	2.5e-05	0.000352	CcSEcCtD
Celecoxib—Vertigo—Betamethasone—ulcerative colitis	2.5e-05	0.000351	CcSEcCtD
Celecoxib—Vertigo—Dexamethasone—ulcerative colitis	2.5e-05	0.000351	CcSEcCtD
Celecoxib—Anaphylactic shock—Methylprednisolone—ulcerative colitis	2.5e-05	0.000351	CcSEcCtD
Celecoxib—Syncope—Betamethasone—ulcerative colitis	2.49e-05	0.00035	CcSEcCtD
Celecoxib—Syncope—Dexamethasone—ulcerative colitis	2.49e-05	0.00035	CcSEcCtD
Celecoxib—Arrhythmia—Prednisone—ulcerative colitis	2.48e-05	0.000349	CcSEcCtD
Celecoxib—Infection—Triamcinolone—ulcerative colitis	2.48e-05	0.000349	CcSEcCtD
Celecoxib—Infection—Methylprednisolone—ulcerative colitis	2.48e-05	0.000348	CcSEcCtD
Celecoxib—Dizziness—Mesalazine—ulcerative colitis	2.47e-05	0.000347	CcSEcCtD
Celecoxib—Shock—Triamcinolone—ulcerative colitis	2.46e-05	0.000346	CcSEcCtD
Celecoxib—Insomnia—Prednisolone—ulcerative colitis	2.46e-05	0.000346	CcSEcCtD
Celecoxib—Alopecia—Prednisone—ulcerative colitis	2.46e-05	0.000345	CcSEcCtD
Celecoxib—Shock—Methylprednisolone—ulcerative colitis	2.45e-05	0.000345	CcSEcCtD
Celecoxib—Nervous system disorder—Methylprednisolone—ulcerative colitis	2.45e-05	0.000344	CcSEcCtD
Celecoxib—Loss of consciousness—Betamethasone—ulcerative colitis	2.44e-05	0.000343	CcSEcCtD
Celecoxib—Loss of consciousness—Dexamethasone—ulcerative colitis	2.44e-05	0.000343	CcSEcCtD
Celecoxib—Paraesthesia—Prednisolone—ulcerative colitis	2.44e-05	0.000343	CcSEcCtD
Celecoxib—Tachycardia—Triamcinolone—ulcerative colitis	2.44e-05	0.000343	CcSEcCtD
Celecoxib—Mental disorder—Prednisone—ulcerative colitis	2.44e-05	0.000343	CcSEcCtD
Celecoxib—Nausea—Azathioprine—ulcerative colitis	2.44e-05	0.000342	CcSEcCtD
Celecoxib—Tachycardia—Methylprednisolone—ulcerative colitis	2.44e-05	0.000342	CcSEcCtD
Celecoxib—Skin disorder—Methylprednisolone—ulcerative colitis	2.42e-05	0.000341	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	2.42e-05	0.00034	CcSEcCtD
Celecoxib—Hyperhidrosis—Triamcinolone—ulcerative colitis	2.42e-05	0.00034	CcSEcCtD
Celecoxib—Hyperhidrosis—Methylprednisolone—ulcerative colitis	2.41e-05	0.000339	CcSEcCtD
Celecoxib—Insomnia—Hydrocortisone—ulcerative colitis	2.4e-05	0.000338	CcSEcCtD
Celecoxib—Hypertension—Betamethasone—ulcerative colitis	2.4e-05	0.000337	CcSEcCtD
Celecoxib—Hypertension—Dexamethasone—ulcerative colitis	2.4e-05	0.000337	CcSEcCtD
Celecoxib—Paraesthesia—Hydrocortisone—ulcerative colitis	2.38e-05	0.000335	CcSEcCtD
Celecoxib—Vomiting—Mesalazine—ulcerative colitis	2.37e-05	0.000334	CcSEcCtD
Celecoxib—Myalgia—Betamethasone—ulcerative colitis	2.37e-05	0.000333	CcSEcCtD
Celecoxib—Myalgia—Dexamethasone—ulcerative colitis	2.37e-05	0.000333	CcSEcCtD
Celecoxib—Anxiety—Betamethasone—ulcerative colitis	2.36e-05	0.000332	CcSEcCtD
Celecoxib—Anxiety—Dexamethasone—ulcerative colitis	2.36e-05	0.000332	CcSEcCtD
Celecoxib—Rash—Mesalazine—ulcerative colitis	2.35e-05	0.000331	CcSEcCtD
Celecoxib—Dermatitis—Mesalazine—ulcerative colitis	2.35e-05	0.000331	CcSEcCtD
Celecoxib—Headache—Mesalazine—ulcerative colitis	2.34e-05	0.000329	CcSEcCtD
Celecoxib—Dyspepsia—Hydrocortisone—ulcerative colitis	2.34e-05	0.000329	CcSEcCtD
Celecoxib—Decreased appetite—Hydrocortisone—ulcerative colitis	2.31e-05	0.000325	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	2.29e-05	0.000322	CcSEcCtD
Celecoxib—Fatigue—Hydrocortisone—ulcerative colitis	2.29e-05	0.000322	CcSEcCtD
Celecoxib—Vision blurred—Prednisone—ulcerative colitis	2.28e-05	0.000321	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	2.28e-05	0.00032	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	2.27e-05	0.00032	CcSEcCtD
Celecoxib—Oedema—Dexamethasone—ulcerative colitis	2.27e-05	0.000319	CcSEcCtD
Celecoxib—Anaphylactic shock—Dexamethasone—ulcerative colitis	2.27e-05	0.000319	CcSEcCtD
Celecoxib—Oedema—Betamethasone—ulcerative colitis	2.27e-05	0.000319	CcSEcCtD
Celecoxib—Anaphylactic shock—Betamethasone—ulcerative colitis	2.27e-05	0.000319	CcSEcCtD
Celecoxib—Insomnia—Triamcinolone—ulcerative colitis	2.26e-05	0.000318	CcSEcCtD
Celecoxib—Insomnia—Methylprednisolone—ulcerative colitis	2.26e-05	0.000317	CcSEcCtD
Celecoxib—Infection—Dexamethasone—ulcerative colitis	2.25e-05	0.000317	CcSEcCtD
Celecoxib—Infection—Betamethasone—ulcerative colitis	2.25e-05	0.000317	CcSEcCtD
Celecoxib—Paraesthesia—Triamcinolone—ulcerative colitis	2.25e-05	0.000316	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisolone—ulcerative colitis	2.24e-05	0.000315	CcSEcCtD
Celecoxib—Paraesthesia—Methylprednisolone—ulcerative colitis	2.24e-05	0.000315	CcSEcCtD
Celecoxib—Anaemia—Prednisone—ulcerative colitis	2.24e-05	0.000315	CcSEcCtD
Celecoxib—Shock—Betamethasone—ulcerative colitis	2.23e-05	0.000314	CcSEcCtD
Celecoxib—Shock—Dexamethasone—ulcerative colitis	2.23e-05	0.000314	CcSEcCtD
Celecoxib—Dyspnoea—Triamcinolone—ulcerative colitis	2.23e-05	0.000313	CcSEcCtD
Celecoxib—Nervous system disorder—Dexamethasone—ulcerative colitis	2.23e-05	0.000313	CcSEcCtD
Celecoxib—Nervous system disorder—Betamethasone—ulcerative colitis	2.23e-05	0.000313	CcSEcCtD
Celecoxib—Thrombocytopenia—Dexamethasone—ulcerative colitis	2.22e-05	0.000312	CcSEcCtD
Celecoxib—Thrombocytopenia—Betamethasone—ulcerative colitis	2.22e-05	0.000312	CcSEcCtD
Celecoxib—Nausea—Mesalazine—ulcerative colitis	2.22e-05	0.000312	CcSEcCtD
Celecoxib—Tachycardia—Dexamethasone—ulcerative colitis	2.21e-05	0.000311	CcSEcCtD
Celecoxib—Tachycardia—Betamethasone—ulcerative colitis	2.21e-05	0.000311	CcSEcCtD
Celecoxib—Angioedema—Prednisone—ulcerative colitis	2.21e-05	0.000311	CcSEcCtD
Celecoxib—Dyspepsia—Triamcinolone—ulcerative colitis	2.2e-05	0.000309	CcSEcCtD
Celecoxib—Dyspepsia—Methylprednisolone—ulcerative colitis	2.2e-05	0.000309	CcSEcCtD
Celecoxib—Hyperhidrosis—Dexamethasone—ulcerative colitis	2.19e-05	0.000308	CcSEcCtD
Celecoxib—Hyperhidrosis—Betamethasone—ulcerative colitis	2.19e-05	0.000308	CcSEcCtD
Celecoxib—Feeling abnormal—Hydrocortisone—ulcerative colitis	2.19e-05	0.000308	CcSEcCtD
Celecoxib—Vertigo—Prednisone—ulcerative colitis	2.18e-05	0.000306	CcSEcCtD
Celecoxib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	2.17e-05	0.000305	CcSEcCtD
Celecoxib—Syncope—Prednisone—ulcerative colitis	2.17e-05	0.000305	CcSEcCtD
Celecoxib—Anorexia—Betamethasone—ulcerative colitis	2.16e-05	0.000304	CcSEcCtD
Celecoxib—Anorexia—Dexamethasone—ulcerative colitis	2.16e-05	0.000304	CcSEcCtD
Celecoxib—Urticaria—Prednisolone—ulcerative colitis	2.16e-05	0.000304	CcSEcCtD
Celecoxib—Fatigue—Triamcinolone—ulcerative colitis	2.16e-05	0.000303	CcSEcCtD
Celecoxib—Fatigue—Methylprednisolone—ulcerative colitis	2.15e-05	0.000302	CcSEcCtD
Celecoxib—Loss of consciousness—Prednisone—ulcerative colitis	2.13e-05	0.000299	CcSEcCtD
Celecoxib—Urticaria—Hydrocortisone—ulcerative colitis	2.11e-05	0.000297	CcSEcCtD
Celecoxib—Abdominal pain—Hydrocortisone—ulcerative colitis	2.1e-05	0.000295	CcSEcCtD
Celecoxib—Body temperature increased—Hydrocortisone—ulcerative colitis	2.1e-05	0.000295	CcSEcCtD
Celecoxib—Hypertension—Prednisone—ulcerative colitis	2.09e-05	0.000294	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	2.07e-05	0.000291	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	2.07e-05	0.000291	CcSEcCtD
Celecoxib—Myalgia—Prednisone—ulcerative colitis	2.06e-05	0.00029	CcSEcCtD
Celecoxib—Arthralgia—Prednisone—ulcerative colitis	2.06e-05	0.00029	CcSEcCtD
Celecoxib—Feeling abnormal—Triamcinolone—ulcerative colitis	2.06e-05	0.00029	CcSEcCtD
Celecoxib—Feeling abnormal—Methylprednisolone—ulcerative colitis	2.06e-05	0.000289	CcSEcCtD
Celecoxib—Anxiety—Prednisone—ulcerative colitis	2.05e-05	0.000289	CcSEcCtD
Celecoxib—Insomnia—Dexamethasone—ulcerative colitis	2.05e-05	0.000288	CcSEcCtD
Celecoxib—Insomnia—Betamethasone—ulcerative colitis	2.05e-05	0.000288	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	2.05e-05	0.000288	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	2.04e-05	0.000287	CcSEcCtD
Celecoxib—Paraesthesia—Dexamethasone—ulcerative colitis	2.04e-05	0.000286	CcSEcCtD
Celecoxib—Paraesthesia—Betamethasone—ulcerative colitis	2.04e-05	0.000286	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisolone—ulcerative colitis	2e-05	0.000282	CcSEcCtD
Celecoxib—Dyspepsia—Dexamethasone—ulcerative colitis	2e-05	0.000281	CcSEcCtD
Celecoxib—Dyspepsia—Betamethasone—ulcerative colitis	2e-05	0.000281	CcSEcCtD
Celecoxib—Urticaria—Triamcinolone—ulcerative colitis	1.99e-05	0.000279	CcSEcCtD
Celecoxib—Urticaria—Methylprednisolone—ulcerative colitis	1.98e-05	0.000279	CcSEcCtD
Celecoxib—Body temperature increased—Triamcinolone—ulcerative colitis	1.98e-05	0.000278	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisone—ulcerative colitis	1.98e-05	0.000278	CcSEcCtD
Celecoxib—Oedema—Prednisone—ulcerative colitis	1.98e-05	0.000278	CcSEcCtD
Celecoxib—Abdominal pain—Methylprednisolone—ulcerative colitis	1.97e-05	0.000277	CcSEcCtD
Celecoxib—Decreased appetite—Dexamethasone—ulcerative colitis	1.97e-05	0.000277	CcSEcCtD
Celecoxib—Decreased appetite—Betamethasone—ulcerative colitis	1.97e-05	0.000277	CcSEcCtD
Celecoxib—Infection—Prednisone—ulcerative colitis	1.96e-05	0.000276	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	1.96e-05	0.000275	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	1.96e-05	0.000275	CcSEcCtD
Celecoxib—Hypersensitivity—Hydrocortisone—ulcerative colitis	1.96e-05	0.000275	CcSEcCtD
Celecoxib—Fatigue—Betamethasone—ulcerative colitis	1.96e-05	0.000275	CcSEcCtD
Celecoxib—Fatigue—Dexamethasone—ulcerative colitis	1.96e-05	0.000275	CcSEcCtD
Celecoxib—Shock—Prednisone—ulcerative colitis	1.94e-05	0.000273	CcSEcCtD
Celecoxib—Nervous system disorder—Prednisone—ulcerative colitis	1.94e-05	0.000272	CcSEcCtD
Celecoxib—Tachycardia—Prednisone—ulcerative colitis	1.93e-05	0.000271	CcSEcCtD
Celecoxib—Skin disorder—Prednisone—ulcerative colitis	1.92e-05	0.00027	CcSEcCtD
Celecoxib—Hyperhidrosis—Prednisone—ulcerative colitis	1.91e-05	0.000269	CcSEcCtD
Celecoxib—Asthenia—Hydrocortisone—ulcerative colitis	1.91e-05	0.000268	CcSEcCtD
Celecoxib—Anorexia—Prednisone—ulcerative colitis	1.88e-05	0.000265	CcSEcCtD
Celecoxib—Pruritus—Hydrocortisone—ulcerative colitis	1.88e-05	0.000264	CcSEcCtD
Celecoxib—Feeling abnormal—Dexamethasone—ulcerative colitis	1.87e-05	0.000263	CcSEcCtD
Celecoxib—Feeling abnormal—Betamethasone—ulcerative colitis	1.87e-05	0.000263	CcSEcCtD
Celecoxib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	1.86e-05	0.000261	CcSEcCtD
Celecoxib—Gastrointestinal pain—Betamethasone—ulcerative colitis	1.86e-05	0.000261	CcSEcCtD
Celecoxib—Hypersensitivity—Triamcinolone—ulcerative colitis	1.84e-05	0.000259	CcSEcCtD
Celecoxib—Hypersensitivity—Methylprednisolone—ulcerative colitis	1.84e-05	0.000258	CcSEcCtD
Celecoxib—Diarrhoea—Hydrocortisone—ulcerative colitis	1.82e-05	0.000255	CcSEcCtD
Celecoxib—Urticaria—Betamethasone—ulcerative colitis	1.8e-05	0.000253	CcSEcCtD
Celecoxib—Urticaria—Dexamethasone—ulcerative colitis	1.8e-05	0.000253	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	1.8e-05	0.000253	CcSEcCtD
Celecoxib—Dizziness—Prednisolone—ulcerative colitis	1.8e-05	0.000253	CcSEcCtD
Celecoxib—Asthenia—Triamcinolone—ulcerative colitis	1.79e-05	0.000252	CcSEcCtD
Celecoxib—Abdominal pain—Dexamethasone—ulcerative colitis	1.79e-05	0.000252	CcSEcCtD
Celecoxib—Abdominal pain—Betamethasone—ulcerative colitis	1.79e-05	0.000252	CcSEcCtD
Celecoxib—Body temperature increased—Betamethasone—ulcerative colitis	1.79e-05	0.000252	CcSEcCtD
Celecoxib—Body temperature increased—Dexamethasone—ulcerative colitis	1.79e-05	0.000252	CcSEcCtD
Celecoxib—Asthenia—Methylprednisolone—ulcerative colitis	1.79e-05	0.000252	CcSEcCtD
Celecoxib—Insomnia—Prednisone—ulcerative colitis	1.79e-05	0.000251	CcSEcCtD
Celecoxib—Paraesthesia—Prednisone—ulcerative colitis	1.77e-05	0.000249	CcSEcCtD
Celecoxib—Pruritus—Triamcinolone—ulcerative colitis	1.77e-05	0.000249	CcSEcCtD
Celecoxib—Pruritus—Methylprednisolone—ulcerative colitis	1.77e-05	0.000248	CcSEcCtD
Celecoxib—Dizziness—Hydrocortisone—ulcerative colitis	1.76e-05	0.000247	CcSEcCtD
Celecoxib—Dyspepsia—Prednisone—ulcerative colitis	1.74e-05	0.000244	CcSEcCtD
Celecoxib—Decreased appetite—Prednisone—ulcerative colitis	1.72e-05	0.000241	CcSEcCtD
Celecoxib—Rash—Prednisolone—ulcerative colitis	1.71e-05	0.000241	CcSEcCtD
Celecoxib—Dermatitis—Prednisolone—ulcerative colitis	1.71e-05	0.000241	CcSEcCtD
Celecoxib—Diarrhoea—Methylprednisolone—ulcerative colitis	1.71e-05	0.00024	CcSEcCtD
Celecoxib—Fatigue—Prednisone—ulcerative colitis	1.7e-05	0.000239	CcSEcCtD
Celecoxib—Headache—Prednisolone—ulcerative colitis	1.7e-05	0.000239	CcSEcCtD
Celecoxib—Constipation—Prednisone—ulcerative colitis	1.69e-05	0.000238	CcSEcCtD
Celecoxib—Vomiting—Hydrocortisone—ulcerative colitis	1.69e-05	0.000237	CcSEcCtD
Celecoxib—Rash—Hydrocortisone—ulcerative colitis	1.67e-05	0.000235	CcSEcCtD
Celecoxib—Dermatitis—Hydrocortisone—ulcerative colitis	1.67e-05	0.000235	CcSEcCtD
Celecoxib—Headache—Hydrocortisone—ulcerative colitis	1.66e-05	0.000234	CcSEcCtD
Celecoxib—Dizziness—Triamcinolone—ulcerative colitis	1.65e-05	0.000232	CcSEcCtD
Celecoxib—Dizziness—Methylprednisolone—ulcerative colitis	1.65e-05	0.000232	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisone—ulcerative colitis	1.63e-05	0.000229	CcSEcCtD
Celecoxib—Asthenia—Dexamethasone—ulcerative colitis	1.63e-05	0.000229	CcSEcCtD
Celecoxib—Asthenia—Betamethasone—ulcerative colitis	1.63e-05	0.000229	CcSEcCtD
Celecoxib—Gastrointestinal pain—Prednisone—ulcerative colitis	1.62e-05	0.000227	CcSEcCtD
Celecoxib—Nausea—Prednisolone—ulcerative colitis	1.62e-05	0.000227	CcSEcCtD
Celecoxib—Pruritus—Betamethasone—ulcerative colitis	1.61e-05	0.000226	CcSEcCtD
Celecoxib—Pruritus—Dexamethasone—ulcerative colitis	1.61e-05	0.000226	CcSEcCtD
Celecoxib—Vomiting—Triamcinolone—ulcerative colitis	1.59e-05	0.000223	CcSEcCtD
Celecoxib—Vomiting—Methylprednisolone—ulcerative colitis	1.59e-05	0.000223	CcSEcCtD
Celecoxib—Nausea—Hydrocortisone—ulcerative colitis	1.58e-05	0.000222	CcSEcCtD
Celecoxib—Rash—Triamcinolone—ulcerative colitis	1.58e-05	0.000222	CcSEcCtD
Celecoxib—Dermatitis—Triamcinolone—ulcerative colitis	1.58e-05	0.000221	CcSEcCtD
Celecoxib—Rash—Methylprednisolone—ulcerative colitis	1.57e-05	0.000221	CcSEcCtD
Celecoxib—Dermatitis—Methylprednisolone—ulcerative colitis	1.57e-05	0.000221	CcSEcCtD
Celecoxib—Urticaria—Prednisone—ulcerative colitis	1.57e-05	0.000221	CcSEcCtD
Celecoxib—Headache—Triamcinolone—ulcerative colitis	1.57e-05	0.00022	CcSEcCtD
Celecoxib—Headache—Methylprednisolone—ulcerative colitis	1.56e-05	0.00022	CcSEcCtD
Celecoxib—Abdominal pain—Prednisone—ulcerative colitis	1.56e-05	0.00022	CcSEcCtD
Celecoxib—Body temperature increased—Prednisone—ulcerative colitis	1.56e-05	0.00022	CcSEcCtD
Celecoxib—Diarrhoea—Betamethasone—ulcerative colitis	1.55e-05	0.000218	CcSEcCtD
Celecoxib—Diarrhoea—Dexamethasone—ulcerative colitis	1.55e-05	0.000218	CcSEcCtD
Celecoxib—Dizziness—Dexamethasone—ulcerative colitis	1.5e-05	0.000211	CcSEcCtD
Celecoxib—Dizziness—Betamethasone—ulcerative colitis	1.5e-05	0.000211	CcSEcCtD
Celecoxib—Nausea—Triamcinolone—ulcerative colitis	1.49e-05	0.000209	CcSEcCtD
Celecoxib—Nausea—Methylprednisolone—ulcerative colitis	1.48e-05	0.000208	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisone—ulcerative colitis	1.46e-05	0.000205	CcSEcCtD
Celecoxib—Vomiting—Betamethasone—ulcerative colitis	1.44e-05	0.000203	CcSEcCtD
Celecoxib—Vomiting—Dexamethasone—ulcerative colitis	1.44e-05	0.000203	CcSEcCtD
Celecoxib—Rash—Betamethasone—ulcerative colitis	1.43e-05	0.000201	CcSEcCtD
Celecoxib—Rash—Dexamethasone—ulcerative colitis	1.43e-05	0.000201	CcSEcCtD
Celecoxib—Dermatitis—Dexamethasone—ulcerative colitis	1.43e-05	0.000201	CcSEcCtD
Celecoxib—Dermatitis—Betamethasone—ulcerative colitis	1.43e-05	0.000201	CcSEcCtD
Celecoxib—Headache—Betamethasone—ulcerative colitis	1.42e-05	0.0002	CcSEcCtD
Celecoxib—Headache—Dexamethasone—ulcerative colitis	1.42e-05	0.0002	CcSEcCtD
Celecoxib—Asthenia—Prednisone—ulcerative colitis	1.42e-05	0.000199	CcSEcCtD
Celecoxib—Pruritus—Prednisone—ulcerative colitis	1.4e-05	0.000197	CcSEcCtD
Celecoxib—Diarrhoea—Prednisone—ulcerative colitis	1.35e-05	0.00019	CcSEcCtD
Celecoxib—Nausea—Dexamethasone—ulcerative colitis	1.35e-05	0.000189	CcSEcCtD
Celecoxib—Nausea—Betamethasone—ulcerative colitis	1.35e-05	0.000189	CcSEcCtD
Celecoxib—Dizziness—Prednisone—ulcerative colitis	1.31e-05	0.000184	CcSEcCtD
Celecoxib—Vomiting—Prednisone—ulcerative colitis	1.26e-05	0.000177	CcSEcCtD
Celecoxib—Rash—Prednisone—ulcerative colitis	1.25e-05	0.000175	CcSEcCtD
Celecoxib—Dermatitis—Prednisone—ulcerative colitis	1.24e-05	0.000175	CcSEcCtD
Celecoxib—Headache—Prednisone—ulcerative colitis	1.24e-05	0.000174	CcSEcCtD
Celecoxib—Nausea—Prednisone—ulcerative colitis	1.17e-05	0.000165	CcSEcCtD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.5e-06	0.000223	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—IL6—ulcerative colitis	9.48e-06	0.000223	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RIPK2—ulcerative colitis	9.45e-06	0.000222	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—MMP1—ulcerative colitis	9.44e-06	0.000222	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FCGR2A—ulcerative colitis	9.42e-06	0.000221	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CRP—ulcerative colitis	9.42e-06	0.000221	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—NFKB1—ulcerative colitis	9.41e-06	0.000221	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MAML2—ulcerative colitis	9.31e-06	0.000219	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	9.26e-06	0.000218	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	9.21e-06	0.000216	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—NFKB1—ulcerative colitis	9.14e-06	0.000215	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ABCB1—ulcerative colitis	9.12e-06	0.000214	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—NFKB1—ulcerative colitis	9.04e-06	0.000212	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTPN2—ulcerative colitis	9.03e-06	0.000212	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—TLR4—ulcerative colitis	9.03e-06	0.000212	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HLA-DRB1—ulcerative colitis	9.02e-06	0.000212	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—ulcerative colitis	9e-06	0.000211	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—IL6—ulcerative colitis	8.99e-06	0.000211	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PPARG—ulcerative colitis	8.96e-06	0.00021	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	8.89e-06	0.000209	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ADCY5—ulcerative colitis	8.87e-06	0.000208	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ALB—ulcerative colitis	8.85e-06	0.000208	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	8.85e-06	0.000208	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	8.83e-06	0.000207	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	8.78e-06	0.000206	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—DLD—ulcerative colitis	8.75e-06	0.000205	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TGFB1—ulcerative colitis	8.71e-06	0.000204	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCR1—ulcerative colitis	8.68e-06	0.000204	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ICAM1—ulcerative colitis	8.66e-06	0.000203	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	8.65e-06	0.000203	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ALB—ulcerative colitis	8.63e-06	0.000203	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ALB—ulcerative colitis	8.63e-06	0.000203	CbGpPWpGaD
Celecoxib—PTGS2—Disease—LTF—ulcerative colitis	8.62e-06	0.000203	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—NFKB1—ulcerative colitis	8.57e-06	0.000201	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ADCY5—ulcerative colitis	8.51e-06	0.0002	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CRP—ulcerative colitis	8.4e-06	0.000197	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PPARG—ulcerative colitis	8.3e-06	0.000195	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—ulcerative colitis	8.3e-06	0.000195	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—STAT3—ulcerative colitis	8.21e-06	0.000193	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CHP1—ulcerative colitis	8.2e-06	0.000193	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ADRB2—ulcerative colitis	8.2e-06	0.000193	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ALB—ulcerative colitis	8.17e-06	0.000192	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	8.12e-06	0.000191	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—PPARG—ulcerative colitis	8.11e-06	0.00019	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—JAK2—ulcerative colitis	8.09e-06	0.00019	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—TLR4—ulcerative colitis	8.06e-06	0.000189	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ALB—ulcerative colitis	8.05e-06	0.000189	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—ulcerative colitis	7.74e-06	0.000182	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CALM3—ulcerative colitis	7.71e-06	0.000181	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—STAT3—ulcerative colitis	7.71e-06	0.000181	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.68e-06	0.00018	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ABCB1—ulcerative colitis	7.68e-06	0.00018	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CDH1—ulcerative colitis	7.65e-06	0.00018	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	7.63e-06	0.000179	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL20—ulcerative colitis	7.62e-06	0.000179	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—CALM3—ulcerative colitis	7.6e-06	0.000178	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—JAK2—ulcerative colitis	7.6e-06	0.000178	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RIPK2—ulcerative colitis	7.6e-06	0.000178	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—ulcerative colitis	7.59e-06	0.000178	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	7.57e-06	0.000178	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—ulcerative colitis	7.55e-06	0.000177	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—ulcerative colitis	7.55e-06	0.000177	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTLA4—ulcerative colitis	7.49e-06	0.000176	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ALB—ulcerative colitis	7.46e-06	0.000175	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CXCL8—ulcerative colitis	7.38e-06	0.000173	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—JAK2—ulcerative colitis	7.34e-06	0.000172	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ADCY5—ulcerative colitis	7.17e-06	0.000168	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—ulcerative colitis	7.17e-06	0.000168	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GNA12—ulcerative colitis	7.16e-06	0.000168	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ALB—ulcerative colitis	7.15e-06	0.000168	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	7.14e-06	0.000168	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD79A—ulcerative colitis	7.14e-06	0.000168	CbGpPWpGaD
Celecoxib—ALB—Metabolism—DLD—ulcerative colitis	7.08e-06	0.000166	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.07e-06	0.000166	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL2—ulcerative colitis	7.05e-06	0.000166	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—ulcerative colitis	7.04e-06	0.000165	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	7e-06	0.000164	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	6.98e-06	0.000164	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ADCY5—ulcerative colitis	6.96e-06	0.000163	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NOD2—ulcerative colitis	6.89e-06	0.000162	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD14—ulcerative colitis	6.85e-06	0.000161	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCR2—ulcerative colitis	6.79e-06	0.00016	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—JAK2—ulcerative colitis	6.78e-06	0.000159	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CHP1—ulcerative colitis	6.77e-06	0.000159	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CHP1—ulcerative colitis	6.71e-06	0.000158	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—JAK2—ulcerative colitis	6.71e-06	0.000158	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CXCL8—ulcerative colitis	6.7e-06	0.000157	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	6.67e-06	0.000157	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—JAK2—ulcerative colitis	6.65e-06	0.000156	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2—ulcerative colitis	6.63e-06	0.000156	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PPARG—ulcerative colitis	6.62e-06	0.000155	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—VCAM1—ulcerative colitis	6.61e-06	0.000155	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DQA1—ulcerative colitis	6.59e-06	0.000155	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IFNG—ulcerative colitis	6.59e-06	0.000155	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—RELA—ulcerative colitis	6.57e-06	0.000154	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—ulcerative colitis	6.53e-06	0.000153	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—RELA—ulcerative colitis	6.5e-06	0.000153	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2—ulcerative colitis	6.41e-06	0.00015	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR6—ulcerative colitis	6.39e-06	0.00015	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD4—ulcerative colitis	6.36e-06	0.000149	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PPARG—ulcerative colitis	6.34e-06	0.000149	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	6.3e-06	0.000148	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	6.29e-06	0.000148	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—ulcerative colitis	6.27e-06	0.000147	CbGpPWpGaD
Celecoxib—PDPK1—Disease—JAK2—ulcerative colitis	6.2e-06	0.000146	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC11A1—ulcerative colitis	6.15e-06	0.000144	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAML2—ulcerative colitis	6.05e-06	0.000142	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—JAK2—ulcerative colitis	5.99e-06	0.000141	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—VDR—ulcerative colitis	5.95e-06	0.00014	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ALB—ulcerative colitis	5.95e-06	0.00014	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—ulcerative colitis	5.91e-06	0.000139	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	5.88e-06	0.000138	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL1B—ulcerative colitis	5.88e-06	0.000138	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD4—ulcerative colitis	5.87e-06	0.000138	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2—ulcerative colitis	5.85e-06	0.000137	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DLD—ulcerative colitis	5.85e-06	0.000137	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—ulcerative colitis	5.83e-06	0.000137	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	5.82e-06	0.000137	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2—ulcerative colitis	5.8e-06	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—RELA—ulcerative colitis	5.8e-06	0.000136	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DLD—ulcerative colitis	5.79e-06	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—ulcerative colitis	5.74e-06	0.000135	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ALB—ulcerative colitis	5.7e-06	0.000134	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD4—ulcerative colitis	5.68e-06	0.000133	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTGER4—ulcerative colitis	5.62e-06	0.000132	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—ulcerative colitis	5.6e-06	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ADCY5—ulcerative colitis	5.59e-06	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NFKB1—ulcerative colitis	5.54e-06	0.00013	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAML2—ulcerative colitis	5.52e-06	0.00013	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NFKB1—ulcerative colitis	5.48e-06	0.000129	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—ulcerative colitis	5.38e-06	0.000126	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PPARG—ulcerative colitis	5.35e-06	0.000126	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—ulcerative colitis	5.2e-06	0.000122	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	5.19e-06	0.000122	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TGFB1—ulcerative colitis	5.17e-06	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GHRL—ulcerative colitis	5.15e-06	0.000121	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	5.12e-06	0.00012	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—ulcerative colitis	4.99e-06	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CALM3—ulcerative colitis	4.99e-06	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—STAT3—ulcerative colitis	4.98e-06	0.000117	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—STAT3—ulcerative colitis	4.93e-06	0.000116	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RIPK2—ulcerative colitis	4.91e-06	0.000115	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CRP—ulcerative colitis	4.89e-06	0.000115	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NFKB1—ulcerative colitis	4.89e-06	0.000115	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MMP1—ulcerative colitis	4.88e-06	0.000115	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ALB—ulcerative colitis	4.81e-06	0.000113	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.77e-06	0.000112	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TLR4—ulcerative colitis	4.69e-06	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DRB1—ulcerative colitis	4.69e-06	0.00011	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.63e-06	0.000109	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—ulcerative colitis	4.61e-06	0.000108	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CALM3—ulcerative colitis	4.55e-06	0.000107	CbGpPWpGaD
Celecoxib—PDPK1—Disease—STAT3—ulcerative colitis	4.55e-06	0.000107	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	4.54e-06	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—ulcerative colitis	4.52e-06	0.000106	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ICAM1—ulcerative colitis	4.5e-06	0.000106	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CHP1—ulcerative colitis	4.43e-06	0.000104	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—JAK2—ulcerative colitis	4.34e-06	0.000102	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—ulcerative colitis	4.31e-06	0.000101	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRB2—ulcerative colitis	4.26e-06	0.0001	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—ulcerative colitis	4.25e-06	9.99e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PTGS1—ulcerative colitis	4.23e-06	9.93e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—ulcerative colitis	4.22e-06	9.9e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—ulcerative colitis	4.21e-06	9.88e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RELA—ulcerative colitis	4.2e-06	9.87e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.16e-06	9.77e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PPARG—ulcerative colitis	4.15e-06	9.74e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDH1—ulcerative colitis	3.98e-06	9.34e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL8—ulcerative colitis	3.96e-06	9.3e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DLD—ulcerative colitis	3.82e-06	8.97e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CALM3—ulcerative colitis	3.81e-06	8.94e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—ulcerative colitis	3.78e-06	8.89e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—ulcerative colitis	3.77e-06	8.84e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.74e-06	8.79e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—ulcerative colitis	3.73e-06	8.75e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADCY5—ulcerative colitis	3.62e-06	8.49e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—ulcerative colitis	3.58e-06	8.41e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NFKB1—ulcerative colitis	3.54e-06	8.32e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—JAK2—ulcerative colitis	3.49e-06	8.19e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—ulcerative colitis	3.48e-06	8.16e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—ulcerative colitis	3.44e-06	8.08e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—JAK2—ulcerative colitis	3.44e-06	8.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—ulcerative colitis	3.42e-06	8.04e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS1—ulcerative colitis	3.42e-06	8.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RELA—ulcerative colitis	3.38e-06	7.93e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD4—ulcerative colitis	3.31e-06	7.76e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ADCY5—ulcerative colitis	3.3e-06	7.75e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—STAT3—ulcerative colitis	3.18e-06	7.48e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—ulcerative colitis	3.18e-06	7.46e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CALM3—ulcerative colitis	3.08e-06	7.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—ulcerative colitis	3.07e-06	7.21e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.06e-06	7.2e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—ulcerative colitis	3.05e-06	7.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—ulcerative colitis	3.04e-06	7.14e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—ulcerative colitis	3e-06	7.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCB1—ulcerative colitis	2.96e-06	6.96e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—ulcerative colitis	2.95e-06	6.93e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.94e-06	6.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NFKB1—ulcerative colitis	2.85e-06	6.69e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS1—ulcerative colitis	2.83e-06	6.64e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS1—ulcerative colitis	2.8e-06	6.58e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ADCY5—ulcerative colitis	2.76e-06	6.49e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.76e-06	6.47e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STAT3—ulcerative colitis	2.56e-06	6.01e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CALM3—ulcerative colitis	2.54e-06	5.98e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.52e-06	5.92e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—ulcerative colitis	2.43e-06	5.71e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.41e-06	5.66e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCB1—ulcerative colitis	2.4e-06	5.63e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—ulcerative colitis	2.34e-06	5.49e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JAK2—ulcerative colitis	2.25e-06	5.3e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADCY5—ulcerative colitis	2.24e-06	5.25e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—ulcerative colitis	2.22e-06	5.22e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RELA—ulcerative colitis	2.18e-06	5.13e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—ulcerative colitis	2.06e-06	4.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—ulcerative colitis	2.06e-06	4.83e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—JAK2—ulcerative colitis	2.06e-06	4.83e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCB1—ulcerative colitis	1.98e-06	4.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—ulcerative colitis	1.97e-06	4.62e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.96e-06	4.61e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—ulcerative colitis	1.95e-06	4.58e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—ulcerative colitis	1.93e-06	4.52e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—ulcerative colitis	1.86e-06	4.37e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—ulcerative colitis	1.85e-06	4.35e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.85e-06	4.34e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADCY5—ulcerative colitis	1.85e-06	4.33e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NFKB1—ulcerative colitis	1.84e-06	4.32e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.83e-06	4.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—ulcerative colitis	1.79e-06	4.2e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—ulcerative colitis	1.67e-06	3.92e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.66e-06	3.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT3—ulcerative colitis	1.65e-06	3.89e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—ulcerative colitis	1.53e-06	3.6e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STAT3—ulcerative colitis	1.51e-06	3.55e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—ulcerative colitis	1.4e-06	3.29e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—ulcerative colitis	1.38e-06	3.23e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.36e-06	3.2e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—ulcerative colitis	1.31e-06	3.08e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.29e-06	3.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—ulcerative colitis	1.26e-06	2.97e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—ulcerative colitis	1.24e-06	2.91e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—ulcerative colitis	1.23e-06	2.88e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.21e-06	2.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—ulcerative colitis	1.16e-06	2.71e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.08e-06	2.54e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.07e-06	2.52e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—ulcerative colitis	1.05e-06	2.48e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—ulcerative colitis	9e-07	2.11e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—ulcerative colitis	8.09e-07	1.9e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	7.08e-07	1.66e-05	CbGpPWpGaD
